Cancer Treatment - The Times Of Central Asia

Viewing results 1 - 6 of 4

Cancer Treatment

Uzbekistan Cancer Care Reforms to be Launched in 2027

Uzbekistan plans to overhaul cancer care from 2027, with reforms aimed at detecting tumors earlier and expanding palliative support for patients outside the country’s main medical centers. The National Cancer Control Program, developed with the participation of the World Health Organization and international experts, aims to bring oncology services closer to international standards while improving access to care in the regions. The proposals point to one of the central weaknesses in cancer care across much of the region: patients are often diagnosed late and forced to travel to major cities for specialist treatment. Two key metrics for the plan are firstly to increase targeted screening coverage for common cancers is to 60%, while the five-year survival rate among cancer patients is expected to increase from the current 35% to at least 45%. To achieve these goals, primary healthcare workers will receive additional training to identify early signs of cancer and ensure timely referrals to specialized medical institutions. That would put family doctors and local clinics at the center of the reform, rather than leaving patients to navigate the system only after symptoms have become harder to treat. The focus on primary care also fits a wider shift in Uzbekistan’s health policy. There is already a major effort to move more treatment and prevention work out of hospitals and into local clinics, with early intervention presented as a way to reduce pressure on specialist facilities. Officials also plan to establish rapid diagnostic pathways to shorten the time between initial examinations and confirmed diagnoses. Radiation therapy services will be also be modernized, with aging cobalt therapy equipment gradually replaced with modern linear accelerators. The equipment upgrades follow other recent moves to expand Uzbekistan’s specialist cancer infrastructure. TCA reported earlier this year that a Nuclear Medicine Center under construction in Tashkent is expected to be equipped with PET/CT scanners, a cyclotron, a radiopharmaceutical laboratory, and Gamma Knife and CyberKnife systems. A significant part of the reform package concerns palliative and hospice care. Beginning September 1, 2026, Uzbekistan plans to establish a unified nationwide system by integrating medical and social services. Mobile palliative care teams providing home-based medical and social services will be created, with every region of the country getting its own hospice institutions. A children’s palliative care center for patients with severe and incurable illnesses is also planned in the Samarkand region. The palliative-care proposals address one of the more visible gaps in Uzbekistan’s cancer system. Uzbekistan’s first children’s oncology hospice opened in Tashkent in August 2022, while plans for an adult hospice in the capital had been delayed for years. Authorities expect palliative and hospice care coverage to reach at least 80% by 2030. Patients requiring home care will receive specialized equipment, including functional beds and mattresses, through a voucher system. Family members will also be able to access a new “Family Support” service. The proposals additionally include social support measures for employees of state healthcare institutions. These include partial compensation of university tuition fees for the children of medical workers with...

Cancer Treatment

Diagnosis and a Suitcase: Why Kazakhstanis with Cancer Still Seek Treatment Abroad

Fundraising appeals for cancer treatment abroad have become a familiar feature of Kazakhstan’s social media landscape. A photograph, a medical report, a bank account number and a plea for help often signal a family’s decision that treatment outside the country offers the best chance of survival. Whether that perception is justified remains one of the most sensitive questions facing Kazakhstan’s healthcare system. According to the Ministry of Health, the incidence of malignant neoplasms in urban areas reached approximately 239 cases per 100,000 people in 2024, up from 230 a year earlier. Kazakhstan records one of the highest cancer incidence rates in Central Asia, ahead of Kyrgyzstan, Uzbekistan, Turkmenistan and Tajikistan, according to recent regional comparisons. More than 30,000 new cancer cases are diagnosed in Kazakhstan each year, while thousands of people die annually from malignant tumors. Breast cancer is the most commonly diagnosed form of the disease, followed by colorectal and lung cancers. Lung cancer remains one of the leading causes of cancer-related mortality. The burden of disease is not evenly distributed. The highest incidence rates are recorded in industrial regions such as Pavlodar, Karaganda, Kostanay, North Kazakhstan and East Kazakhstan. Specialists attribute the trend to a combination of environmental pollution, unhealthy lifestyles, population aging and, according to some experts, the long-term effects of the COVID-19 pandemic. Kazakhstan’s leading oncologists generally reject the notion that treatment abroad is automatically better. The country’s major oncology centers offer surgery, chemotherapy and radiation therapy using treatment protocols that largely correspond to international standards. Physicians at the National Research Oncology Center in Astana note that many patients who travel to Turkey or South Korea eventually receive treatment recommendations similar to those available in Kazakhstan, often at a much higher personal cost. The difference, doctors and patients say, often lies in speed and service. Private clinics abroad can offer faster access to consultations, diagnostics and treatment, while patients frequently cite more personalized care and greater attention from medical staff. For families confronting a life-threatening diagnosis, such factors can become decisive. At the same time, some limitations within Kazakhstan’s healthcare system are difficult to ignore. The country’s bone marrow donor registry remains relatively small. In leukemia cases where no compatible donor can be found among relatives, patients often depend on international registries and may require treatment abroad. Organ transplantation from deceased donors also remains underdeveloped. In some cases of liver cancer, patients must travel to countries such as Belarus when no living donor is available. Some of the latest targeted therapies and immunotherapy drugs are also not yet registered in Kazakhstan, although oncologists say new treatments are gradually being incorporated into clinical practice. One of the most common complaints among patients with cancer in Kazakhstan concerns delays in diagnostics and treatment. Kazakhstan’s healthcare system formally guarantees a so-called “green corridor” for oncology patients, under which no more than 30 days should pass between the initial suspicion of cancer and the start of treatment. In practice, however, access to high-tech diagnostic equipment remains uneven. PET/CT scanners, a...

Healthcare

Kazakhstan to Expand Use of AI for Early Detection of Strokes and Cancer

Kazakhstan’s Ministry of Health is moving to expand the use of AI to improve early diagnosis of strokes, cancer, and other high-impact diseases. Officials say the rollout aims to reduce mortality, increase diagnostic accuracy, and ease the workload of healthcare professionals. According to the ministry, a list of priority AI initiatives has been compiled to help detect socially significant diseases at early stages and support clinical decision-making. The targeted areas include stroke, lung cancer, breast cancer, and dental diagnostics through the analysis of medical imagery using machine learning algorithms. Several platforms are already operational and are being integrated more widely into the national healthcare system. Among the current AI platforms in use: Cerebra – deployed in nine category II and III stroke centers across five regions, capable of identifying stroke symptoms in under three minutes; WDsoft – used in 190 healthcare facilities in 10 regions to assist in the early detection of cancer and pneumonia; AIDENTIS – adopted by 65 dental clinics and three medical universities to analyze X-ray imagery; ALIMA – an AI-based medical assistant now active in over 700 clinics nationwide. The ALIMA platform processes patient complaints, medical records, and images to suggest potential diagnoses, recommend examinations, and propose treatment plans aligned with clinical protocols. These AI initiatives rely on computing resources provided by the Ministry of Artificial Intelligence and Digital Development, including eight graphics processors, and are supported through API-based integrations. Looking ahead, the Ministry of Health intends to introduce AI tools to evaluate pharmaceuticals and medical devices and to launch a project for early detection of chronic heart failure using the Smart ECG system. This technology enables remote interpretation of electrocardiograms in clinics that lack specialized functional diagnostics staff. As previously reported by The Times of Central Asia, Kazakhstani surgeons recently conducted the region's first joint replacement surgeries in Tashkent using the MAKO robotic system, another example of the country’s growing investment in med-tech innovation.

Healthcare

Kazakhstan and Uzbekistan Strengthen Cooperation on Cancer Treatment and Child Health

At the high-level conference, “Dialogue for Children: Central Asia and UNICEF,” held recently in Tashkent, the health ministers of Kazakhstan and Uzbekistan met to expand bilateral cooperation in healthcare. Kazakhstan’s Health Minister Akmaral Alnazarova and her Uzbek counterpart Asilbek Khudayarov discussed a range of initiatives aimed at enhancing the quality of medical services in both countries. According to the Uzbek Health Ministry, the discussions focused on joint research projects, the exchange of medical expertise, and collaboration within the coalition of countries supporting primary healthcare. The two sides also considered conducting environmental studies in the Aral Sea region to assess the health impacts of local ecological conditions. Focus on Pediatric Health and Cancer Treatment Children’s health emerged as a central theme in the talks. Kazakhstan proposed establishing an international academic hub for childhood cancer and offered to take the lead on the initiative. Minister Alnazarova outlined Kazakhstan’s use of advanced diagnostic and treatment methods for pediatric cancer, including immunohistochemistry, immunophenotyping, tumor marker detection, high-dose chemotherapy for bone and soft tissue sarcomas, and organ-preserving surgeries. She also announced that a new Proton Therapy Center will open in Astana this October. The center is expected to treat over 800 patients annually and will offer radioiodine therapy for children from across Central Asia. Kazakhstan also proposed creating two additional international hubs: one for adult oncology and oncohematology, and another for pediatric heart surgery at the UMC Heart Center. The heart surgery hub would be open to patients from Uzbekistan, including children from Karakalpakstan. Alnazarova noted that several areas of Kazakhstan’s healthcare system now meet international standards, with hospitals adopting globally recognized technologies and practices. Expanding Bilateral Healthcare Ties To deepen bilateral engagement, the two ministers agreed to hold “Kazakhstan Medicine Days” in Uzbekistan in 2025, followed by “Uzbekistan Medicine Days” in Kazakhstan in 2026. They also endorsed the creation of an international healthcare hub to promote cross-border collaboration. In a related development, Kazakhstan’s Minister of Science and Higher Education, Sayasat Nurbek, announced in March that the country is developing a new anti-cancer drug. Phase II clinical trials, completed last year, showed promising results, including an average tumor size reduction of 30%. The drug is expected to be registered and released to the market by the end of 2024.